Sympathetic, but ultimately, we die OF diseases. And the years we do have are more or less valuable depending on their quality.
Physicians should maximize QALYs, and extending lifespan is only one way to do it.
Sympathetic, but ultimately, we die OF diseases.
The question is whether that’s a useful paradigm. Aubrey Gray argues that it isn’t.
Sympathetic, but ultimately, we die OF diseases. And the years we do have are more or less valuable depending on their quality.
Physicians should maximize QALYs, and extending lifespan is only one way to do it.
The question is whether that’s a useful paradigm. Aubrey Gray argues that it isn’t.